Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Naarden Jacob Van. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Naarden Jacob Van reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:LLY / Eli Lilly and Company EVP,Pres LLY Oncology&HdCorpBD 26,626
US:LOXO / Loxo Oncology, Inc. Chief Operating Officer 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Naarden Jacob Van. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Naarden Jacob Van conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2026-02-11 2026-02-09 4 LLY ELI LILLY & Co
Common Stock
A - Award 4,866 26,626 22.36 1,044.67 5,083,247 27,815,904
2026-02-03 2026-02-01 4 LLY ELI LILLY & Co
Common Stock
F - Taxes -1,909 22,761 -7.74 1,037.15 -1,980,308 23,606,167
2026-02-03 2026-02-01 4 LLY ELI LILLY & Co
Common Stock
M - Exercise 4,108 24,670 19.98
2025-08-13 2025-08-13 4 LLY ELI LILLY & Co
Common Stock
P - Purchase 1,000 20,562 5.11 647.36 647,360 13,311,007
2025-02-12 2025-02-10 4 LLY ELI LILLY & Co
Common Stock
A - Award 6,104 19,562 45.35 868.88 5,303,491 16,997,018
2025-02-04 2025-02-01 4 LLY ELI LILLY & Co
Common Stock
F - Taxes -1,410 13,458 -9.48 811.08 -1,143,492 10,915,645
2025-02-04 2025-02-01 4 LLY ELI LILLY & Co
Common Stock
M - Exercise 3,023 14,868 25.52
2024-11-01 2024-10-31 4 LLY ELI LILLY & Co
Common Stock
G - Gift -4,302 11,845 -26.64
2024-02-14 2024-02-12 4 LLY ELI LILLY & Co
Common Stock
A - Award 2,369 16,147 17.19 737.26 1,746,569 11,904,537
2024-02-02 2024-02-01 4 LLY ELI LILLY & Co
Common Stock
F - Taxes -1,685 13,778 -10.90 645.61 -1,087,853 8,895,215
2024-02-02 2024-02-01 4 LLY ELI LILLY & Co
Common Stock
M - Exercise 3,618 15,463 30.54
2023-02-21 2023-02-16 4 LLY ELI LILLY & Co
Common Stock
F - Taxes -1,314 11,845 -9.99 335.01 -440,203 3,968,193
2023-02-21 2023-02-16 4 LLY ELI LILLY & Co
Common Stock
M - Exercise 2,785 13,159 26.85
2023-02-14 2023-02-10 4 LLY ELI LILLY & Co
Common Stock
A - Award 2,407 10,374 30.21 345.12 830,704 3,580,275
2022-02-17 2022-02-16 4 LLY ELI LILLY & Co
Restricted Stock Unit
M - Exercise -5,461 0 -100.00
2022-02-17 2022-02-16 4 LLY ELI LILLY & Co
Common Stock
F - Taxes -2,186 7,967 -21.53 243.84 -533,034 1,942,673
2022-02-17 2022-02-16 4 LLY ELI LILLY & Co
Common Stock
M - Exercise 5,461 10,153 116.39
2021-12-30 2021-12-28 4 LLY ELI LILLY & Co
Restricted Stock Unit
A - Award 3,618 3,618
2021-09-07 3 LLY ELI LILLY & Co
Common Stock
4,692
2021-09-07 3 LLY ELI LILLY & Co
Common Stock
4,342
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -57,000 0 -100.00 235.00 -13,395,000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -200,000 0 -100.00 235.00 -47,000,000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -35,000 0 -100.00 235.00 -8,225,000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -74,000 0 -100.00 235.00 -17,390,000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -43,000 0 -100.00 235.00 -10,105,000
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -78,943 0 -100.00 235.00 -18,551,605
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
D - Sale to Issuer -35,026 0 -100.00 235.00 -8,231,110
2019-02-15 2019-02-15 4 LOXO Loxo Oncology, Inc.
Common Stock
D - Sale to Issuer -19,000 0 -100.00 235.00 -4,465,000
2019-01-17 2018-07-09 4/A LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 13,541 12.84 3.65 5,622 49,398
2019-01-02 2019-01-02 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
A - Award 57,000 57,000
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise -7,000 33,326 -17.36
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -4,500 78,943 -5.39
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise 7,000 20,700 51.09 3.65 25,536 75,514
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -541 13,700 -3.80 140.16 -75,827 1,920,192
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 14,241 -3.39 139.23 -69,615 1,982,774
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 14,741 -3.28 137.73 -68,865 2,030,278
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,759 15,241 -10.35 137.09 -241,141 2,089,389
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -800 17,000 -4.49 135.92 -108,736 2,310,640
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 17,800 -2.20 134.74 -53,896 2,398,372
2018-12-12 2018-12-11 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 4,500 18,200 32.85 13.67 61,515 248,794
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -4,500 83,443 -5.12
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 13,700 -0.72 137.39 -13,739 1,882,243
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,800 -1.43 136.48 -27,296 1,883,424
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 14,000 -3.45 135.14 -67,570 1,891,960
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,400 14,500 -8.81 134.65 -188,510 1,952,425
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -900 15,900 -5.36 133.17 -119,853 2,117,403
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,000 16,800 -5.62 132.23 -132,230 2,221,464
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 17,800 -2.20 130.59 -52,236 2,324,502
2018-12-12 2018-12-10 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 4,500 18,200 32.85 13.67 61,515 248,794
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -2,057 87,943 -2.29
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -2,443 40,326 -5.71
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,700 -1.44 151.55 -30,310 2,076,235
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,900 -1.42 149.46 -29,892 2,077,494
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -81 14,100 -0.57 147.99 -11,987 2,086,659
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 14,181 -2.07 147.06 -44,118 2,085,458
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 14,481 -0.69 144.97 -14,497 2,099,311
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 14,581 -1.35 143.92 -28,784 2,098,498
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 14,781 -3.27 143.08 -71,540 2,114,865
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 15,281 -3.17 141.69 -70,845 2,165,165
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 15,781 -1.87 140.13 -42,039 2,211,392
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,170 16,081 -6.78 138.83 -162,431 2,232,525
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -949 17,251 -5.21 138.08 -131,038 2,382,018
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 2,057 18,200 12.74 13.67 28,119 248,794
2018-11-28 2018-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 2,443 16,143 17.83 3.65 8,912 58,890
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,500 42,769 -11.39
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,700 -1.44 156.45 -31,290 2,143,365
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 13,900 -4.14 155.30 -93,180 2,158,670
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,500 14,500 -9.38 154.00 -231,000 2,233,000
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,644 16,000 -9.32 152.49 -250,694 2,439,840
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,556 17,644 -8.10 151.71 -236,061 2,676,771
2018-11-28 2018-11-26 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 5,500 19,200 40.15 3.65 20,064 70,042
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 13,700 -4.20 164.68 -98,806 2,256,071
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,006 14,300 -6.57 163.78 -164,767 2,342,118
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,194 15,306 -7.24 162.70 -194,265 2,490,302
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,100 16,500 -6.25 161.52 -177,673 2,665,088
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 17,600 -3.30 160.62 -96,373 2,826,942
2018-10-05 2018-10-04 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 4,500 18,200 32.85 3.65 16,416 66,394
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,500 52,769 -9.44
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 13,700 -2.14 169.40 -50,820 2,320,780
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2,300 14,000 -14.11 168.85 -388,347 2,363,851
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 16,300 -2.98 167.19 -83,596 2,725,230
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 16,800 -2.33 165.88 -66,354 2,786,868
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2,000 17,200 -10.42 165.13 -330,261 2,840,241
2018-10-05 2018-10-03 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 5,500 19,200 40.15 3.65 20,064 70,042
2018-10-05 2001-10-04 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -4,500 48,269 -8.53
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -4,500 58,269 -7.17
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 13,700 -2.14 167.49 -50,246 2,294,568
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,500 14,000 -9.68 166.63 -249,952 2,332,886
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -2,700 15,500 -14.84 165.45 -446,705 2,564,418
2018-09-14 2018-09-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 4,500 18,200 32.85 3.65 16,416 66,394
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,500 62,769 -8.06
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 13,700 -4.20 171.03 -102,616 2,343,066
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 14,300 -1.38 168.78 -33,757 2,413,626
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,000 14,500 -6.45 167.39 -167,392 2,427,184
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,059 15,500 -6.40 166.74 -176,576 2,584,439
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,885 16,559 -10.22 165.32 -311,620 2,737,461
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -756 18,444 -3.94 164.44 -124,315 3,032,900
2018-09-14 2018-09-12 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 5,500 19,200 40.15 3.65 20,064 70,042
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -4,500 68,269 -6.18
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -701 13,700 -4.87 160.70 -112,650 2,201,586
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3,199 14,401 -18.18 159.91 -511,542 2,302,821
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 17,600 -3.30 159.08 -95,449 2,799,843
2018-08-15 2018-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 4,500 18,200 32.85 3.65 16,416 66,394
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -5,500 72,769 -7.03
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,700 -1.44 160.60 -32,119 2,200,152
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,500 13,900 -9.74 159.69 -239,534 2,219,681
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -3,070 15,400 -16.62 158.66 -487,092 2,443,393
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -730 18,470 -3.80 157.62 -115,059 2,911,158
2018-08-15 2018-08-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 5,500 19,200 40.15 3.65 20,064 70,042
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 78,269 -1.93
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 13,700 -0.72 183.19 -18,319 2,509,703
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 13,800 -0.72 181.96 -18,196 2,511,048
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 13,900 -2.11 180.95 -54,284 2,515,159
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -361 14,200 -2.48 179.50 -64,800 2,548,909
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -680 14,561 -4.46 178.39 -121,308 2,597,599
2018-07-11 2018-07-10 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 15,241 11.25 3.65 5,622 55,599
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 79,810 -1.89
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 13,700 -0.72 191.64 -19,164 2,625,468
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 13,800 -0.72 189.12 -18,912 2,609,856
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 13,900 -1.42 188.04 -37,608 2,613,756
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -641 14,100 -4.35 187.37 -120,107 2,641,986
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 14,741 -1.34 186.19 -37,238 2,744,627
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 14,941 -1.97 185.34 -55,602 2,769,168
2018-07-11 2018-07-09 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 15,241 11.25 3.65 5,622 55,599
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 83,051 -1.82
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -12,000 84,592 -12.42
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 12,000 -1.64 180.90 -36,180 2,170,800
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 12,200 -1.61 179.76 -35,951 2,193,011
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,141 12,400 -8.43 179.00 -204,239 2,219,601
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 13,541 12.84 3.65 5,622 49,398
2018-06-21 2018-06-20 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise 12,000 12,000 3.65 43,776 43,776
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 96,592 -1.57
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 0 -100.00 178.23 -17,823
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -576 100 -85.21 177.47 -102,221 17,747
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -865 676 -56.13 176.44 -152,622 119,274
2018-06-21 2018-06-19 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 98,133 -1.55
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 0 -100.00 139.04 -27,808
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -841 200 -80.79 138.35 -116,354 27,670
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 1,041 -22.37 135.78 -40,734 141,347
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 1,341 -12.98 133.35 -26,670 178,822
2018-05-16 2018-05-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 99,674 -1.52
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -9 0 -100.00 139.45 -1,255
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -691 9 -98.71 138.70 -95,842 1,248
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 700 -46.15 137.50 -82,497 96,247
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -241 1,300 -15.64 134.25 -32,354 174,524
2018-05-16 2018-05-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 101,215 -1.50
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -541 0 -100.00 132.05 -71,442
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 541 -52.59 130.94 -78,561 70,836
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 1,141 -8.06 129.45 -12,945 147,702
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 1,241 -19.47 128.72 -38,615 159,737
2018-04-26 2018-04-25 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 102,756 -1.48
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 0 -100.00 133.09 -66,543
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 500 -50.00 131.88 -65,941 65,941
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 1,000 -23.08 130.62 -39,185 130,617
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -241 1,300 -15.64 129.58 -31,229 168,455
2018-04-26 2018-04-24 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 104,297 -1.46
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -646 0 -100.00 132.02 -85,287
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -895 646 -58.08 131.05 -117,293 84,661
2018-03-15 2018-03-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 105,838 -1.44
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 0 -100.00 134.05 -13,405
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -441 100 -81.52 132.48 -58,423 13,248
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 541 -42.51 131.40 -52,562 71,090
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 941 -34.70 130.28 -65,140 122,593
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 1,441 -6.49 128.85 -12,885 185,673
2018-03-15 2018-03-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 107,379 -1.41
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,041 0 -100.00 101.05 -105,188
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 1,041 -8.76 97.87 -9,787 101,883
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 1,141 -8.06 96.60 -9,660 110,221
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 1,241 -19.47 94.33 -28,299 117,064
2018-02-14 2018-02-13 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 108,920 -1.40
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 0 -100.00 94.49 -28,348
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -741 300 -71.18 93.83 -69,525 28,148
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 1,041 -32.45 92.21 -46,105 95,991
2018-02-14 2018-02-12 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 110,461 -1.38
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 0 -100.00 89.86 -17,973
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -695 200 -77.65 89.23 -62,012 17,845
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 895 -18.26 87.96 -17,592 78,724
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -446 1,095 -28.94 86.30 -38,488 94,493
2018-01-18 2018-01-17 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 112,002 -1.36
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 0 -100.00 90.45 -9,045
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 100 -83.33 90.07 -45,035 9,007
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 600 -14.29 88.36 -8,836 53,016
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 700 -22.22 87.10 -17,419 60,966
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -641 900 -41.60 86.53 -55,467 77,878
2018-01-18 2018-01-16 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2018-01-05 2018-01-04 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 200,000 200,000
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 113,543 -1.34
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 0 -100.00 82.86 -8,286
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 100 -66.67 80.79 -16,158 8,079
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -241 300 -44.55 79.69 -19,205 23,907
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 541 -52.59 78.72 -47,231 42,587
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 1,141 -25.96 77.60 -31,041 88,544
2017-12-18 2017-12-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 115,084 -1.32
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 0 -100.00 84.01 -58,808
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -841 700 -54.57 82.65 -69,511 57,857
2017-12-18 2017-12-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 116,625 -1.30
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -441 0 -100.00 75.52 -33,304
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -500 441 -53.13 74.03 -37,017 32,649
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -600 941 -38.94 73.27 -43,961 68,945
2017-11-29 2017-11-28 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 118,166 -1.29
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -300 0 -100.00 76.76 -23,029
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 300 -57.14 74.96 -29,985 22,489
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -841 700 -54.57 74.08 -62,302 51,857
2017-11-29 2017-11-27 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 119,707 -1.27
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -400 0 -100.00 86.94 -34,778
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,141 400 -74.04 86.37 -98,543 34,546
2017-11-01 2017-10-31 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 121,248 -1.25
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -200 0 -100.00 88.77 -17,754
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -241 200 -54.65 87.78 -21,155 17,556
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,100 441 -71.38 86.87 -95,559 38,310
2017-11-01 2017-10-30 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 122,789 -1.24
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -100 0 -100.00 89.76 -8,976
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -944 100 -90.42 89.18 -84,185 8,918
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -497 1,044 -32.25 87.86 -43,667 91,727
2017-09-20 2017-09-19 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 124,330 -1.22
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -485 0 -100.00 89.99 -43,646
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -700 485 -59.07 89.20 -62,438 43,261
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -356 1,185 -23.10 88.14 -31,378 104,445
2017-09-20 2017-09-18 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 125,871 -1.21
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,541 0 -100.00 73.42 -113,134
2017-08-16 2017-08-15 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1,541 127,412 -1.20
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -541 0 -100.00 74.07 -40,074
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
S - Sale X -1,000 541 -64.89 73.54 -73,545 39,788
2017-08-16 2017-08-14 4 LOXO Loxo Oncology, Inc.
Common Stock
M - Exercise X 1,541 1,541 3.65 5,622 5,622
2017-03-17 2017-03-15 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 35,000 35,000
2016-12-08 2016-12-06 4 LOXO Loxo Oncology, Inc.
Employee Stock Option (right to buy)
A - Award 74,000 74,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)